1KOVARIK JM,BURTIN P.Immunosuppressants in Advanced Clinical Development for Organ Transplantation and Selected Autoimmune Diseases[J].Expert Opin Emerg Drugs(S1472-8214),2003,8(1):47-62.
2CREE B.Emerging Monoclonal Antibody Therapies for Multipie Sclerosis[J].Neurologist(SL074-7931),2006,12(4):171-178.
4PONSETI JM,AZEM J,FORT JM,et al.Experience with Starting Tacrolimus P0stoperatively after Transsternal Extended Thymectomy in Patients with Myasthenia Gravis[J].Curr Med Res Opin(S0300-7995),2006,22(5):885-895.
5TADA M,sHIMOHATA T,TADA M,et al.Long-term Therapeutic Efficacy and Safety of Low-dose Tacrolimus (FK506)for Myasthenia Gravis[J].J Neurol Sci(S0022-510X),2006,247(1):17-20.
6MITSUI T,KUNISHIGE M,ICHIMIYA M,et al.Beneficial Effect of Tacrolimus on Myasthenia Gravis with Thymoma[J].Neurologist(S1074-7931),2007,13(2):83-86.
7KONISHI T,YOSHIYAMA Y,TAKAMORl M,et al.Clinical Study of FK506 in Patients with Myasthenia Gravis[J].Muscle Nerve(S0148-639X),2003,28(5):570-574.
8KONISHI T,YOSHIYAMA Y,TAKAMORI M,et al.Long-term Treatment of Generalised Myasthenia Gravis with FK506(Tacrolimus)[J].J Neurol Neurosurg Psychiatry (S0022-3050),2005,76(3):448-450.
10MERIGGIOLI MN,CIAFALONI E,AL-HAYK KA,et al.Mycophenolate Mofetil for Myasthenia Gravis:an Analysis of Efficacy,Safety and Tolerability[J].Neurology(S0028-3878),2003,61:1438-1440.
二级参考文献20
1Jaretzki A 3rd,Barohn RJ,Ernstoff RM,et al.Myasthenia gravis:recommendations for clinical research standards.Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America[J].Neurology,2000,55:16-23
3Drachman DB,Jones RJ,Brodsky RA.Treatment of refractory myasthenia:"rebooting" with high-dose cyclophosphamide [ J ].Ann Neurol,2003,53:29-34
4Ciaf aloni E,Massey JM,Tucker-Lipscomb B,et al.Mycophenolate mofetil for myasthenia gravis:an open-label pilot study[ J].Neurology,2001,56:97-99
5Wolfe GI,Herbelin L,Nations SP,et al.Myasthenia gravis activities of daily living profile[J].Neurology,1999,52:1487-1489
6Flanagan WM,Corthesy B,Bram RJ,et al.Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A [ J ].Nature,1991,352:803-807
7Duddridge M,Powell RJ.Treatment of severe and difficult cases of systemic lupus erythematosus with tacrolimus.A report of three cases[J].Ann Rheum Dis,1997,56:690-692
8von Hahn T,Stopik D,Koch M,et al.Management of severe refractory adult autoimmune enteropathy with infliximab and tacrolimus [ J ].Digestion,2005,71:141-144
9Aqel BA,Machicao V,Rosser B,et al.Efficacy of tacrolimus in the treatment of steroid refractory autoinnune hepatitis [ J ].J Clin Gastroenterol,2004,38:805-809
10Yoshikawa H,Iwasa K,SatohK,et al.Treatment of severe and difficult cases of systemic lupus erythematosus with tacrolinus.A report of three cases[J].J Autoimmun,1997,10:11-16
